Cannabinoids in urology. Which benign conditions might they be appropriate to treat: A systematic review

There is growing evidence suggesting cannabinoids may provide suitable alternatives to conventional treatments in an increasing number of clinical settings. This review evaluates how cannabinoids are used to treat certain benign urological pathologies and to clarify the clinical value of this data. This review includes 62 papers and was undertaken per PRISMA's guidelines, it evidences the therapeutic potential of cannabinoids in the management of specific benign urological diseases, most notably neurogenic bladder dysfunction (clinical studies), renal disease (animal studies) and interstitial cystitis (animal studies).

Source: Urology - October 28, 2020 Category: Urology & Nephrology Authors: C Taylor, B Birch Source Type: research